Lexpos News

/Lexpos News

Update – Pfizer brands now available as generics

Update 24/07/2025 – Latest update on branded stock availability (as of 24/07/2025) and addition of Premique® Low Dose 0.3mg/1.5mg modified-release tablets to the table below. Update 17/06/2025 – Correction to PIP codes in the table below. Pharmacy teams should be aware that Pfizer Limited has recently ceased supplying a number of its well-established brands and released [...]

The post Update – Pfizer brands now available as generics appeared first on Community Pharmacy England.

By |June 11th, 2025|Lexpos News|Comments Off on Update – Pfizer brands now available as generics

Government announces Spending Review Outcome

The Government’s Spending Review has concluded, with Chancellor Rachel Reeves today announcing the Government’s new spending priorities. The announcement included a 3% real terms uplift to NHS funding, for each of the coming three years, with the Government reiterating its commitment to its three shifts for healthcare: moving care closer to home, from treatment to [...]

The post Government announces Spending Review Outcome appeared first on Community Pharmacy England.

By |June 11th, 2025|Lexpos News|Comments Off on Government announces Spending Review Outcome

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare)

MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets, Opella Healthcare Drug alert number: EL(25)A/26 Date issued: 10 June 2025 Opella Healthcare UK LTD has informed the MHRA that there is an error on the artwork for the outer carton of Dulcolax® Adult 5mg GR Tablets (packsize 20 count). The dose instruction incorrectly states [...]

The post MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare) appeared first on Community Pharmacy England.

By |June 10th, 2025|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Notification: Dulcolax® Adult 5mg gastro-resistant tablets (Opella Healthcare)

Are you confident in making clinical records?

As the provision of clinical services in community pharmacies continues to grow, pharmacy professionals who want to update their knowledge of best practice in record keeping can access the Centre for Pharmacy Postgraduate Education Documenting in patient clinical records e-learning programme. This learning programme will support pharmacy professionals to: Summarise the legal and regulatory requirements [...]

The post Are you confident in making clinical records? appeared first on Community Pharmacy England.

By |June 10th, 2025|Lexpos News|Comments Off on Are you confident in making clinical records?

MHRA Class 2 Medicines Recall: Paracetamol 500mg Tablets (Chelonia Healthcare Limited)

MHRA Class 2 Medicines Notification: Paracetamol 500mg Tablets (Chelonia Healthcare Limited) Drug alert number: EL(25)A/25 Date issued: 09 June 2025 Chelonia Healthcare Limited is recalling specific batches of Paracetamol 500mg Tablets (100 pots) as a precautionary measure due to contamination following a small number of complaints of discoloured tablets within the pots. DMRC reference number: [...]

The post MHRA Class 2 Medicines Recall: Paracetamol 500mg Tablets (Chelonia Healthcare Limited) appeared first on Community Pharmacy England.

By |June 9th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Paracetamol 500mg Tablets (Chelonia Healthcare Limited)